The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Entrectinib Market Research Report 2025
Synopsis
Entrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well as ROS1 and ALK, with high potency and selectivity. RXDX-101 has demonstrated potent pharmacological activity in preclinical studies and has the potential to be first-in-class against the Trk family of kinases. PXDX-101 has been well tolerated in patients with advanced solid tumors. PXDX-101 is currently in clinical trials, and is being developed by Ignyta.
The global Entrectinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Entrectinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Entrectinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Entrectinib include BOCSCI, APExBIO Technology, Cayman Chemical, ChemScence, Crysdot, Medical Isotopes, TargetMol Chemicals, Toronto Research Chemicals and Beijing Jingming Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Entrectinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Entrectinib.
Report Scope
The Entrectinib market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Entrectinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Entrectinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BOCSCI
APExBIO Technology
Cayman Chemical
ChemScence
Crysdot
Medical Isotopes
TargetMol Chemicals
Toronto Research Chemicals
Beijing Jingming Biotechnology
Cool Pharm
Shanghai Lollane Biological Technology
Shanghai Macklin Biochemical
Shanghai Muse Health Tech
ATK Chemical
Shanghai Send Pharmaceutical Technology
Shanghai Yuanye Bio-Technology
Wuhan Sun-Shine Bio-Technology
Segment by Type
0.99
0.98
Segment by Application
Anaplastic Lymphoma
C-ros Oncogene
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Entrectinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Entrectinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Entrectinib, also known as RXDX-101 and NMS-E628, is an oral small molecule inhibitor of TrkA, TrkB and TrkC, as well as ROS1 and ALK, with high potency and selectivity. RXDX-101 has demonstrated potent pharmacological activity in preclinical studies and has the potential to be first-in-class against the Trk family of kinases. PXDX-101 has been well tolerated in patients with advanced solid tumors. PXDX-101 is currently in clinical trials, and is being developed by Ignyta.
The global Entrectinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Entrectinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Entrectinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Entrectinib include BOCSCI, APExBIO Technology, Cayman Chemical, ChemScence, Crysdot, Medical Isotopes, TargetMol Chemicals, Toronto Research Chemicals and Beijing Jingming Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Entrectinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Entrectinib.
Report Scope
The Entrectinib market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Entrectinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Entrectinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BOCSCI
APExBIO Technology
Cayman Chemical
ChemScence
Crysdot
Medical Isotopes
TargetMol Chemicals
Toronto Research Chemicals
Beijing Jingming Biotechnology
Cool Pharm
Shanghai Lollane Biological Technology
Shanghai Macklin Biochemical
Shanghai Muse Health Tech
ATK Chemical
Shanghai Send Pharmaceutical Technology
Shanghai Yuanye Bio-Technology
Wuhan Sun-Shine Bio-Technology
Segment by Type
0.99
0.98
Segment by Application
Anaplastic Lymphoma
C-ros Oncogene
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Entrectinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Entrectinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Entrectinib Market Overview
1.1 Product Overview and Scope of Entrectinib
1.2 Entrectinib Segment by Type
1.2.1 Global Entrectinib Market Value Comparison by Type (2024-2030)
1.2.2 0.99
1.2.3 0.98
1.3 Entrectinib Segment by Application
1.3.1 Global Entrectinib Market Value by Application: (2024-2030)
1.3.2 Anaplastic Lymphoma
1.3.3 C-ros Oncogene
1.4 Global Entrectinib Market Size Estimates and Forecasts
1.4.1 Global Entrectinib Revenue 2019-2030
1.4.2 Global Entrectinib Sales 2019-2030
1.4.3 Global Entrectinib Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Entrectinib Market Competition by Manufacturers
2.1 Global Entrectinib Sales Market Share by Manufacturers (2019-2024)
2.2 Global Entrectinib Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Entrectinib Average Price by Manufacturers (2019-2024)
2.4 Global Entrectinib Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Entrectinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Entrectinib, Product Type & Application
2.7 Entrectinib Market Competitive Situation and Trends
2.7.1 Entrectinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Entrectinib Players Market Share by Revenue
2.7.3 Global Entrectinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Entrectinib Retrospective Market Scenario by Region
3.1 Global Entrectinib Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Entrectinib Global Entrectinib Sales by Region: 2019-2030
3.2.1 Global Entrectinib Sales by Region: 2019-2024
3.2.2 Global Entrectinib Sales by Region: 2025-2030
3.3 Global Entrectinib Global Entrectinib Revenue by Region: 2019-2030
3.3.1 Global Entrectinib Revenue by Region: 2019-2024
3.3.2 Global Entrectinib Revenue by Region: 2025-2030
3.4 North America Entrectinib Market Facts & Figures by Country
3.4.1 North America Entrectinib Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Entrectinib Sales by Country (2019-2030)
3.4.3 North America Entrectinib Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Entrectinib Market Facts & Figures by Country
3.5.1 Europe Entrectinib Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Entrectinib Sales by Country (2019-2030)
3.5.3 Europe Entrectinib Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Entrectinib Market Facts & Figures by Country
3.6.1 Asia Pacific Entrectinib Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Entrectinib Sales by Country (2019-2030)
3.6.3 Asia Pacific Entrectinib Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Entrectinib Market Facts & Figures by Country
3.7.1 Latin America Entrectinib Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Entrectinib Sales by Country (2019-2030)
3.7.3 Latin America Entrectinib Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Entrectinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Entrectinib Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Entrectinib Sales by Country (2019-2030)
3.8.3 Middle East and Africa Entrectinib Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Entrectinib Sales by Type (2019-2030)
4.1.1 Global Entrectinib Sales by Type (2019-2024)
4.1.2 Global Entrectinib Sales by Type (2025-2030)
4.1.3 Global Entrectinib Sales Market Share by Type (2019-2030)
4.2 Global Entrectinib Revenue by Type (2019-2030)
4.2.1 Global Entrectinib Revenue by Type (2019-2024)
4.2.2 Global Entrectinib Revenue by Type (2025-2030)
4.2.3 Global Entrectinib Revenue Market Share by Type (2019-2030)
4.3 Global Entrectinib Price by Type (2019-2030)
5 Segment by Application
5.1 Global Entrectinib Sales by Application (2019-2030)
5.1.1 Global Entrectinib Sales by Application (2019-2024)
5.1.2 Global Entrectinib Sales by Application (2025-2030)
5.1.3 Global Entrectinib Sales Market Share by Application (2019-2030)
5.2 Global Entrectinib Revenue by Application (2019-2030)
5.2.1 Global Entrectinib Revenue by Application (2019-2024)
5.2.2 Global Entrectinib Revenue by Application (2025-2030)
5.2.3 Global Entrectinib Revenue Market Share by Application (2019-2030)
5.3 Global Entrectinib Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BOCSCI
6.1.1 BOCSCI Corporation Information
6.1.2 BOCSCI Description and Business Overview
6.1.3 BOCSCI Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BOCSCI Entrectinib Product Portfolio
6.1.5 BOCSCI Recent Developments/Updates
6.2 APExBIO Technology
6.2.1 APExBIO Technology Corporation Information
6.2.2 APExBIO Technology Description and Business Overview
6.2.3 APExBIO Technology Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.2.4 APExBIO Technology Entrectinib Product Portfolio
6.2.5 APExBIO Technology Recent Developments/Updates
6.3 Cayman Chemical
6.3.1 Cayman Chemical Corporation Information
6.3.2 Cayman Chemical Description and Business Overview
6.3.3 Cayman Chemical Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cayman Chemical Entrectinib Product Portfolio
6.3.5 Cayman Chemical Recent Developments/Updates
6.4 ChemScence
6.4.1 ChemScence Corporation Information
6.4.2 ChemScence Description and Business Overview
6.4.3 ChemScence Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ChemScence Entrectinib Product Portfolio
6.4.5 ChemScence Recent Developments/Updates
6.5 Crysdot
6.5.1 Crysdot Corporation Information
6.5.2 Crysdot Description and Business Overview
6.5.3 Crysdot Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Crysdot Entrectinib Product Portfolio
6.5.5 Crysdot Recent Developments/Updates
6.6 Medical Isotopes
6.6.1 Medical Isotopes Corporation Information
6.6.2 Medical Isotopes Description and Business Overview
6.6.3 Medical Isotopes Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Medical Isotopes Entrectinib Product Portfolio
6.6.5 Medical Isotopes Recent Developments/Updates
6.7 TargetMol Chemicals
6.6.1 TargetMol Chemicals Corporation Information
6.6.2 TargetMol Chemicals Description and Business Overview
6.6.3 TargetMol Chemicals Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TargetMol Chemicals Entrectinib Product Portfolio
6.7.5 TargetMol Chemicals Recent Developments/Updates
6.8 Toronto Research Chemicals
6.8.1 Toronto Research Chemicals Corporation Information
6.8.2 Toronto Research Chemicals Description and Business Overview
6.8.3 Toronto Research Chemicals Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Toronto Research Chemicals Entrectinib Product Portfolio
6.8.5 Toronto Research Chemicals Recent Developments/Updates
6.9 Beijing Jingming Biotechnology
6.9.1 Beijing Jingming Biotechnology Corporation Information
6.9.2 Beijing Jingming Biotechnology Description and Business Overview
6.9.3 Beijing Jingming Biotechnology Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Jingming Biotechnology Entrectinib Product Portfolio
6.9.5 Beijing Jingming Biotechnology Recent Developments/Updates
6.10 Cool Pharm
6.10.1 Cool Pharm Corporation Information
6.10.2 Cool Pharm Description and Business Overview
6.10.3 Cool Pharm Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cool Pharm Entrectinib Product Portfolio
6.10.5 Cool Pharm Recent Developments/Updates
6.11 Shanghai Lollane Biological Technology
6.11.1 Shanghai Lollane Biological Technology Corporation Information
6.11.2 Shanghai Lollane Biological Technology Entrectinib Description and Business Overview
6.11.3 Shanghai Lollane Biological Technology Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai Lollane Biological Technology Entrectinib Product Portfolio
6.11.5 Shanghai Lollane Biological Technology Recent Developments/Updates
6.12 Shanghai Macklin Biochemical
6.12.1 Shanghai Macklin Biochemical Corporation Information
6.12.2 Shanghai Macklin Biochemical Entrectinib Description and Business Overview
6.12.3 Shanghai Macklin Biochemical Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shanghai Macklin Biochemical Entrectinib Product Portfolio
6.12.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.13 Shanghai Muse Health Tech
6.13.1 Shanghai Muse Health Tech Corporation Information
6.13.2 Shanghai Muse Health Tech Entrectinib Description and Business Overview
6.13.3 Shanghai Muse Health Tech Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shanghai Muse Health Tech Entrectinib Product Portfolio
6.13.5 Shanghai Muse Health Tech Recent Developments/Updates
6.14 ATK Chemical
6.14.1 ATK Chemical Corporation Information
6.14.2 ATK Chemical Entrectinib Description and Business Overview
6.14.3 ATK Chemical Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ATK Chemical Entrectinib Product Portfolio
6.14.5 ATK Chemical Recent Developments/Updates
6.15 Shanghai Send Pharmaceutical Technology
6.15.1 Shanghai Send Pharmaceutical Technology Corporation Information
6.15.2 Shanghai Send Pharmaceutical Technology Entrectinib Description and Business Overview
6.15.3 Shanghai Send Pharmaceutical Technology Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai Send Pharmaceutical Technology Entrectinib Product Portfolio
6.15.5 Shanghai Send Pharmaceutical Technology Recent Developments/Updates
6.16 Shanghai Yuanye Bio-Technology
6.16.1 Shanghai Yuanye Bio-Technology Corporation Information
6.16.2 Shanghai Yuanye Bio-Technology Entrectinib Description and Business Overview
6.16.3 Shanghai Yuanye Bio-Technology Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Shanghai Yuanye Bio-Technology Entrectinib Product Portfolio
6.16.5 Shanghai Yuanye Bio-Technology Recent Developments/Updates
6.17 Wuhan Sun-Shine Bio-Technology
6.17.1 Wuhan Sun-Shine Bio-Technology Corporation Information
6.17.2 Wuhan Sun-Shine Bio-Technology Entrectinib Description and Business Overview
6.17.3 Wuhan Sun-Shine Bio-Technology Entrectinib Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Wuhan Sun-Shine Bio-Technology Entrectinib Product Portfolio
6.17.5 Wuhan Sun-Shine Bio-Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Entrectinib Industry Chain Analysis
7.2 Entrectinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Entrectinib Production Mode & Process
7.4 Entrectinib Sales and Marketing
7.4.1 Entrectinib Sales Channels
7.4.2 Entrectinib Distributors
7.5 Entrectinib Customers
8 Entrectinib Market Dynamics
8.1 Entrectinib Industry Trends
8.2 Entrectinib Market Drivers
8.3 Entrectinib Market Challenges
8.4 Entrectinib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Entrectinib Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Entrectinib Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Entrectinib Market Competitive Situation by Manufacturers in 2023
Table 4. Global Entrectinib Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Entrectinib Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Entrectinib Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Entrectinib Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Entrectinib Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Entrectinib, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Entrectinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Entrectinib, Product Type & Application
Table 12. Global Key Manufacturers of Entrectinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Entrectinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Entrectinib as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Entrectinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Entrectinib Sales by Region (2019-2024) & (Kg)
Table 18. Global Entrectinib Sales Market Share by Region (2019-2024)
Table 19. Global Entrectinib Sales by Region (2025-2030) & (Kg)
Table 20. Global Entrectinib Sales Market Share by Region (2025-2030)
Table 21. Global Entrectinib Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Entrectinib Revenue Market Share by Region (2019-2024)
Table 23. Global Entrectinib Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Entrectinib Revenue Market Share by Region (2025-2030)
Table 25. North America Entrectinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Entrectinib Sales by Country (2019-2024) & (Kg)
Table 27. North America Entrectinib Sales by Country (2025-2030) & (Kg)
Table 28. North America Entrectinib Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Entrectinib Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Entrectinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Entrectinib Sales by Country (2019-2024) & (Kg)
Table 32. Europe Entrectinib Sales by Country (2025-2030) & (Kg)
Table 33. Europe Entrectinib Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Entrectinib Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Entrectinib Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Entrectinib Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Entrectinib Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Entrectinib Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Entrectinib Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Entrectinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Entrectinib Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Entrectinib Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Entrectinib Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Entrectinib Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Entrectinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Entrectinib Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Entrectinib Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Entrectinib Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Entrectinib Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Entrectinib Sales (Kg) by Type (2019-2024)
Table 51. Global Entrectinib Sales (Kg) by Type (2025-2030)
Table 52. Global Entrectinib Sales Market Share by Type (2019-2024)
Table 53. Global Entrectinib Sales Market Share by Type (2025-2030)
Table 54. Global Entrectinib Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Entrectinib Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Entrectinib Revenue Market Share by Type (2019-2024)
Table 57. Global Entrectinib Revenue Market Share by Type (2025-2030)
Table 58. Global Entrectinib Price (US$/Kg) by Type (2019-2024)
Table 59. Global Entrectinib Price (US$/Kg) by Type (2025-2030)
Table 60. Global Entrectinib Sales (Kg) by Application (2019-2024)
Table 61. Global Entrectinib Sales (Kg) by Application (2025-2030)
Table 62. Global Entrectinib Sales Market Share by Application (2019-2024)
Table 63. Global Entrectinib Sales Market Share by Application (2025-2030)
Table 64. Global Entrectinib Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Entrectinib Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Entrectinib Revenue Market Share by Application (2019-2024)
Table 67. Global Entrectinib Revenue Market Share by Application (2025-2030)
Table 68. Global Entrectinib Price (US$/Kg) by Application (2019-2024)
Table 69. Global Entrectinib Price (US$/Kg) by Application (2025-2030)
Table 70. BOCSCI Corporation Information
Table 71. BOCSCI Description and Business Overview
Table 72. BOCSCI Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. BOCSCI Entrectinib Product
Table 74. BOCSCI Recent Developments/Updates
Table 75. APExBIO Technology Corporation Information
Table 76. APExBIO Technology Description and Business Overview
Table 77. APExBIO Technology Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. APExBIO Technology Entrectinib Product
Table 79. APExBIO Technology Recent Developments/Updates
Table 80. Cayman Chemical Corporation Information
Table 81. Cayman Chemical Description and Business Overview
Table 82. Cayman Chemical Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Cayman Chemical Entrectinib Product
Table 84. Cayman Chemical Recent Developments/Updates
Table 85. ChemScence Corporation Information
Table 86. ChemScence Description and Business Overview
Table 87. ChemScence Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. ChemScence Entrectinib Product
Table 89. ChemScence Recent Developments/Updates
Table 90. Crysdot Corporation Information
Table 91. Crysdot Description and Business Overview
Table 92. Crysdot Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. Crysdot Entrectinib Product
Table 94. Crysdot Recent Developments/Updates
Table 95. Medical Isotopes Corporation Information
Table 96. Medical Isotopes Description and Business Overview
Table 97. Medical Isotopes Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Medical Isotopes Entrectinib Product
Table 99. Medical Isotopes Recent Developments/Updates
Table 100. TargetMol Chemicals Corporation Information
Table 101. TargetMol Chemicals Description and Business Overview
Table 102. TargetMol Chemicals Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. TargetMol Chemicals Entrectinib Product
Table 104. TargetMol Chemicals Recent Developments/Updates
Table 105. Toronto Research Chemicals Corporation Information
Table 106. Toronto Research Chemicals Description and Business Overview
Table 107. Toronto Research Chemicals Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Toronto Research Chemicals Entrectinib Product
Table 109. Toronto Research Chemicals Recent Developments/Updates
Table 110. Beijing Jingming Biotechnology Corporation Information
Table 111. Beijing Jingming Biotechnology Description and Business Overview
Table 112. Beijing Jingming Biotechnology Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Beijing Jingming Biotechnology Entrectinib Product
Table 114. Beijing Jingming Biotechnology Recent Developments/Updates
Table 115. Cool Pharm Corporation Information
Table 116. Cool Pharm Description and Business Overview
Table 117. Cool Pharm Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Cool Pharm Entrectinib Product
Table 119. Cool Pharm Recent Developments/Updates
Table 120. Shanghai Lollane Biological Technology Corporation Information
Table 121. Shanghai Lollane Biological Technology Description and Business Overview
Table 122. Shanghai Lollane Biological Technology Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Shanghai Lollane Biological Technology Entrectinib Product
Table 124. Shanghai Lollane Biological Technology Recent Developments/Updates
Table 125. Shanghai Macklin Biochemical Corporation Information
Table 126. Shanghai Macklin Biochemical Description and Business Overview
Table 127. Shanghai Macklin Biochemical Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Shanghai Macklin Biochemical Entrectinib Product
Table 129. Shanghai Macklin Biochemical Recent Developments/Updates
Table 130. Shanghai Muse Health Tech Corporation Information
Table 131. Shanghai Muse Health Tech Description and Business Overview
Table 132. Shanghai Muse Health Tech Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Shanghai Muse Health Tech Entrectinib Product
Table 134. Shanghai Muse Health Tech Recent Developments/Updates
Table 135. ATK Chemical Corporation Information
Table 136. ATK Chemical Description and Business Overview
Table 137. ATK Chemical Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. ATK Chemical Entrectinib Product
Table 139. ATK Chemical Recent Developments/Updates
Table 140. Shanghai Send Pharmaceutical Technology Corporation Information
Table 141. Shanghai Send Pharmaceutical Technology Description and Business Overview
Table 142. Shanghai Send Pharmaceutical Technology Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. Shanghai Send Pharmaceutical Technology Entrectinib Product
Table 144. Shanghai Send Pharmaceutical Technology Recent Developments/Updates
Table 145. Shanghai Yuanye Bio-Technology Corporation Information
Table 146. Shanghai Yuanye Bio-Technology Description and Business Overview
Table 147. Shanghai Yuanye Bio-Technology Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 148. Shanghai Yuanye Bio-Technology Entrectinib Product
Table 149. Shanghai Yuanye Bio-Technology Recent Developments/Updates
Table 150. Wuhan Sun-Shine Bio-Technology Corporation Information
Table 151. Wuhan Sun-Shine Bio-Technology Description and Business Overview
Table 152. Wuhan Sun-Shine Bio-Technology Entrectinib Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 153. Wuhan Sun-Shine Bio-Technology Entrectinib Product
Table 154. Wuhan Sun-Shine Bio-Technology Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Entrectinib Distributors List
Table 158. Entrectinib Customers List
Table 159. Entrectinib Market Trends
Table 160. Entrectinib Market Drivers
Table 161. Entrectinib Market Challenges
Table 162. Entrectinib Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Entrectinib
Figure 2. Global Entrectinib Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Entrectinib Market Share by Type in 2023 & 2030
Figure 4. 0.99 Product Picture
Figure 5. 0.98 Product Picture
Figure 6. Global Entrectinib Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Entrectinib Market Share by Application in 2023 & 2030
Figure 8. Anaplastic Lymphoma
Figure 9. C-ros Oncogene
Figure 10. Global Entrectinib Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Entrectinib Market Size (2019-2030) & (US$ Million)
Figure 12. Global Entrectinib Sales (2019-2030) & (Kg)
Figure 13. Global Entrectinib Average Price (US$/Kg) & (2019-2030)
Figure 14. Entrectinib Report Years Considered
Figure 15. Entrectinib Sales Share by Manufacturers in 2023
Figure 16. Global Entrectinib Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Entrectinib Players: Market Share by Revenue in 2023
Figure 18. Entrectinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Entrectinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Entrectinib Sales Market Share by Country (2019-2030)
Figure 21. North America Entrectinib Revenue Market Share by Country (2019-2030)
Figure 22. United States Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Entrectinib Sales Market Share by Country (2019-2030)
Figure 25. Europe Entrectinib Revenue Market Share by Country (2019-2030)
Figure 26. Germany Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Entrectinib Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Entrectinib Revenue Market Share by Region (2019-2030)
Figure 33. China Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Entrectinib Sales Market Share by Country (2019-2030)
Figure 43. Latin America Entrectinib Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Entrectinib Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Entrectinib Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Entrectinib Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Entrectinib by Type (2019-2030)
Figure 53. Global Revenue Market Share of Entrectinib by Type (2019-2030)
Figure 54. Global Entrectinib Price (US$/Kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Entrectinib by Application (2019-2030)
Figure 56. Global Revenue Market Share of Entrectinib by Application (2019-2030)
Figure 57. Global Entrectinib Price (US$/Kg) by Application (2019-2030)
Figure 58. Entrectinib Value Chain
Figure 59. Entrectinib Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
